Clinical Trial Update: Efficacy and Safety Study of Dermal-Living Skin Replacement to Treat Diabetic Foot Ulcers [Phase 3]

View source ↗

Summary

The Phase 3 efficacy and safety study of Dermal-Living Skin Replacement for diabetic foot ulcers has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcer

Drugs mentioned

• Dermal-Living Skin Replacement

Snippet

Sponsor: University of California, Davis | Conditions: Diabetic Foot Ulcer | Phase 3 | Status: TERMINATED